- Home
- MAXN vs NRXP Comparison
MAXN vs NRXP Comparison
Compare MAXN & NRXP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MAXN
- NRXP
- Stock Information
- Founded
- MAXN 2019
- NRXP 2015
- Country
- MAXN Singapore
- NRXP United States
- Employees
- MAXN N/A
- NRXP N/A
- Industry
- MAXN Semiconductors
- NRXP Biotechnology: Pharmaceutical Preparations
- Sector
- MAXN Technology
- NRXP Health Care
- Exchange
- MAXN Nasdaq
- NRXP Nasdaq
- Market Cap
- MAXN 56.0M
- NRXP 58.5M
- IPO Year
- MAXN N/A
- NRXP N/A
- Fundamental
- Price
- MAXN $3.67
- NRXP $2.60
- Analyst Decision
- MAXN Sell
- NRXP Strong Buy
- Analyst Count
- MAXN 1
- NRXP 4
- Target Price
- MAXN $4.00
- NRXP $29.25
- AVG Volume (30 Days)
- MAXN 143.9K
- NRXP 531.0K
- Earning Date
- MAXN 08-14-2025
- NRXP 08-18-2025
- Dividend Yield
- MAXN N/A
- NRXP N/A
- EPS Growth
- MAXN N/A
- NRXP N/A
- EPS
- MAXN N/A
- NRXP N/A
- Revenue
- MAXN $176,414,000.00
- NRXP N/A
- Revenue This Year
- MAXN $100.37
- NRXP N/A
- Revenue Next Year
- MAXN $24.61
- NRXP $231.16
- P/E Ratio
- MAXN N/A
- NRXP N/A
- Revenue Growth
- MAXN N/A
- NRXP N/A
- 52 Week Low
- MAXN $2.49
- NRXP $1.10
- 52 Week High
- MAXN $14.49
- NRXP $6.01
- Technical
- Relative Strength Index (RSI)
- MAXN 44.78
- NRXP 48.06
- Support Level
- MAXN $3.51
- NRXP $2.26
- Resistance Level
- MAXN $4.48
- NRXP $2.83
- Average True Range (ATR)
- MAXN 0.40
- NRXP 0.24
- MACD
- MAXN -0.06
- NRXP 0.01
- Stochastic Oscillator
- MAXN 17.35
- NRXP 49.28
About MAXN Maxeon Solar Technologies Ltd.
Maxeon Solar Technologies Ltd is engaged in the manufacturing and marketing of premium solar technology. It owns and operates solar cell and panel manufacturing facilities located in Malaysia, Mexico, and the Philippines. The company's primary products are the Maxeon line of interdigitated back contact (IBC) solar cells and panels, and the Performance line (formerly, P-Series) of shingled solar cells and panels. the Maxeon line of solar panels are the highest-efficiency solar panels on the market with an aesthetically pleasing design, and the Performance line of solar panels offers a high-value and cost-effective solution. It is targeted at residential and small-scale commercial customers across the globe. The company derives its revenue from the United States, France, Italy, and others.
About NRXP NRX Pharmaceuticals Inc.
NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. It has announced the commercialization of ZYESAMI (Aviptadil), an application for COVID-related respiratory failure. The company is also developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behavior.